OK We use cookies to enhance your visit to our site and to bring you advertisements that might interest you. Read our Privacy and Cookies policies to find out more.

News Asia Pacific

After events in Tokyo, San Diego and Nice, Shanghai will play host to the 2017 World Summit Tour in November. About 1,200 dental professionals were welcomed in each of the cities of the tour, according to the organisers. (Photograph: Dentsply Sirona)
0 Comments Aug 24, 2017 | News Asia Pacific

Shanghai marks last stop on 2017 World Summit Tour

Post a comment by Dental Tribune International

SHANGHAI, China: After hosting major events in Tokyo in Japan in February, San Diego in the US in May, and Nice in France in June, the 2017 World Summit Tour will make its final stop in Shanghai on 25 and 26 November.

Once again, attendees can again expect an extensive programme of scientific lectures by international and regional speakers, hands-on workshops on various solutions, as well as a display of Dentsply Sirona’s comprehensive portfolio. The company’s products cover the full range of implant treatment, including imaging systems for diagnostics and treatment planning, computer-assisted surgical procedures and bone regenerative materials, as well as a variety of patient-specific CAD/CAM prosthetic solutions, such as ATLANTIS and CEREC.

Congress participants will again be invited to view the poster exhibition, for which dental professionals can submit poster abstracts in the categories of clinical application and research until 15 September. The winning entries in the competition in both groups will be awarded €1,500 each.

With the World Summit Tour, Dentsply Sirona Implants brings together current scientific news with the latest clinical and digital developments in implant dentistry. The theme of the tour—“Because inspiration and confidence matters”—is intended to reflect the company’s dedication to improved oral health and enhanced quality of life for implant patients worldwide.

RELATED ARTICLES
Post a comment Print  |  Send to a friend
0 Comments
Join the Discussion
All comments are subject to approval before appearing. Submit Comment